Li Yue, Zheng Zhe, Li Yanze, Fan Siyuan, Kong Lingyao, Fu Wanrong, Li Zhonggen, Zhang Jianchao, Li Shuang, Liu Zongtao, Liu Chao, Cao Jinhua, Hao Zhenxuan, Xiao Lili, Du Youyou, Wang Xiaofang, Gao Lu
Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, China.
Department of Radiation Oncology Physics and Technology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
Nat Commun. 2025 Jul 10;16(1):6357. doi: 10.1038/s41467-025-61596-2.
Ischemic injury induces a partial mesenchymal shift in endothelial cells (ECs), contributing to impaired vascular regeneration. However, the molecular regulators of this transitional state remain poorly defined. To address this, we performed circular RNA profiling of endothelial cells under ischemic-like conditions and identified a marked upregulation of a circular RNA, named circATXN1. Functional studies revealed that circATXN1 knockdown modulates endothelial phenotype and vascular response after ischemia. Functional studies have shown that knockdown of circATXN1 can regulate the endothelial cell phenotype and vascular response after ischemia. Mechanistically, circATXN1 knockdown enhances the demethylase protein ALKBH5 to reduce the RNA methylation level of the key transcription factor SLUG, thereby stabilizing SLUG. In animal models, suppression of circATXN1 enhances angiogenesis and improves recovery following ischemic injury. Here, we show that circATXN1 regulates partial endothelial-to-mesenchymal transition (EndMT) and angiogenesis by controlling SLUG mRNA methylation dynamics, highlighting its potential as a therapeutic target in ischemic disease.
缺血性损伤会诱导内皮细胞(ECs)发生部分间充质转变,导致血管再生受损。然而,这种过渡状态的分子调节因子仍不清楚。为了解决这个问题,我们对缺血样条件下的内皮细胞进行了环状RNA分析,并鉴定出一种名为circATXN1的环状RNA显著上调。功能研究表明,circATXN1敲低可调节缺血后的内皮细胞表型和血管反应。功能研究表明,circATXN1敲低可调节缺血后的内皮细胞表型和血管反应。机制上,circATXN1敲低增强了去甲基化酶蛋白ALKBH5,以降低关键转录因子SLUG的RNA甲基化水平,从而稳定SLUG。在动物模型中,circATXN1的抑制增强了血管生成并改善了缺血性损伤后的恢复。在这里,我们表明circATXN1通过控制SLUG mRNA甲基化动力学来调节部分内皮-间充质转化(EndMT)和血管生成,突出了其作为缺血性疾病治疗靶点的潜力。